TotalMarketCap

Actuate Therapeutics

ACTUNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$18.430 M

$0.34 -9.41%

Close of 6 Nov 2026

As of 6 Nov 2026, Actuate Therapeutics (ACTU) has a market capitalization of $18.4M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$22.2M

Loss-making

Shares outstanding

24,014,202

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #386Cocrystal PharmaCOCP$19.5M
  2. #387Quoin PharmaceuticalsQNRX$18.5M
  3. #388Actuate TherapeuticsACTU$18.4M
  4. #389Quantum BiopharmaQNTM$17.8M
  5. #390Akari TherapeuticsAKTX$17.5M

What if Actuate Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$513,402.58

Per share 1,532,088× higher

Bitcoin $1.53T

$27,779.32

Per share 82,899× higher

Apple $5.02T

$91,196.91

Per share 272,148× higher

Or at a round number

$50.0M$100.0M$200.0M$500.0M

Where these numbers come from

Share counts and financials for Actuate Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.